← Open Payments lookup

STEPHANIE BOHANNON: Open Payments

NPI 1104459114 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,295 in 124 payments from 13 companies in 2025. Trend: 2023 $1,667 · 2024 $11,091 · 2025 $16,295

Honoraria: $11,250Food & beverage: $2,699Speaker / faculty: $1,500Travel & lodging: $845
CompanyPaymentsAmount
Axsome Therapeutics, Inc.26$12,947
ABBVIE INC.20$1,888
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$400
Vanda Pharmaceuticals Inc.13$349
Neurocrine BioSciences, Inc.9$200
Supernus Pharmaceuticals, Inc.1$119
Teva Pharmaceuticals USA, Inc.4$89
Corium, LLC8$88
Lundbeck LLC4$72
Otsuka America Pharmaceutical, Inc.3$56

Products named: Auvelity, VRAYLAR, CAPLYTA, FANAPT, INGREZZA, REXULTI, Qelbree, AUSTEDO XR.

Industry payments across AR — which companies pay providers there.